Entera Bio Ltd.

NASDAQ: ENTX · Real-Time Price · USD
1.95
0.05 (2.63%)
At close: Aug 21, 2025, 3:59 PM
1.96
0.51%
Pre-market: Aug 22, 2025, 08:40 AM EDT

Entera Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
10.86M 12.57M 8.66M 6.92M 9.13M 9.26M 11.02M 7.58M 9.13M 10.69M 12.31M 14.32M 17.28M 20.11M 24.89M 27.39M 26.93M 16.38M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
81K 92K 80K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
6K 6K 6K 6K 6K 6K 6K 6K 6K 54K 6K 6K 46K 46K 46K n/a n/a n/a
Receivables
n/a 126K 126K 42K 126K n/a n/a n/a 29K 29K 246K 233K 225K 210K 183K 252K 116K 15K
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a 296K -653K n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
8.21M 8.16M 186K 167K 67K 109K 238K 263K 354K 653K 294K 634K 922K 1.32M 254K 459K 863K 1.04M
Total Current Assets
19.31M 21.22M 8.97M 7.34M 9.6M 9.75M 11.26M 8.02M 9.81M 11.37M 12.85M 15.19M 18.43M 21.64M 25.33M 28.11M 27.91M 17.43M
Property-Plant & Equipment
269K 284K 332K 381K 420K 468K 488K 528K 582K 136K 229K 278K 336K 375K 395K 405K 429K 488K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 605K 605K 605K
Total Long-Term Assets
356K 382K 418K 401K 440K 488K 508K 549K 631K 233K 278K 350K 662K 671K 658K 1.01M 1.03M 1.09M
Total Assets
19.67M 21.6M 9.39M 7.74M 10.04M 10.24M 11.77M 8.56M 10.45M 11.61M 13.13M 15.54M 19.09M 22.31M 25.99M 29.12M 28.94M 18.53M
Account Payables
383K 134K 132K 184K 69K 66K 83K 564K 240K 150K 17K 413K 109K 199K 166K 325K 289K 440K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 43K n/a -172K n/a 15K 1.69M 8K 15K
Short-Term Debt
n/a n/a n/a n/a n/a 153K 134K n/a 140K 48K 91K 129K 172K n/a 179K n/a n/a n/a
Other Current Liabilities
556K 384K 339K 428K 644K 318K 366K 980K 982K 903K 842K 249K 777K 1.47M 2.03M 2.39M 2.87M 9.98M
Total Current Liabilities
1.84M 1.62M 1.18M 1.11M 1.29M 1.12M 1.09M 2.03M 1.86M 1.49M 1.34M 1.19M 1.69M 2.33M 3.16M 2.89M 3.35M 10.62M
Long-Term Debt
n/a n/a n/a n/a n/a 224K 256K n/a 316K n/a n/a 3K 5K 98K 123K n/a n/a n/a
Other Long-Term Liabilities
558K 547K 32K 31K 30K -193K -224K 31K -284K 32K 32K 29K 117K 37K 15K 88K 88K 78K
Total Long-Term Liabilities
567K 598K 134K 178K 209K 255K 288K 302K 348K 32K 32K 35K 127K 233K 261K 241K 275K 298K
Total Liabilities
2.41M 2.22M 1.31M 1.29M 1.5M 1.38M 1.38M 2.33M 2.21M 1.53M 1.37M 1.23M 1.82M 2.57M 3.42M 3.13M 3.62M 10.91M
Total Debt
203K 220K 272K 309K 334K 377K 390K 402K 456K 48K 91K 132K 177K 240K 302K 332K 371K 402K
Common Stock
1K 1K 1K 1K 1K 1K 1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Retained Earnings
-119.15M -116.49M -113.93M -111.57M -108.55M -106.4M -104.39M -102.39M -100.01M -97.69M -95.5M -92.46M -89.39M -86.21M -82.43M -90M -87.54M -82.38M
Comprehensive Income
41K 41K 41K 41K 41K 41K 41K 41K 41K 41K 41K 41K 41K 41K 41K 10.18M 9.76M 9.17M
Shareholders Equity
17.26M 19.38M 8.08M 6.45M 8.53M 8.86M 10.39M 6.24M 8.23M 10.08M 11.75M 14.31M 17.27M 19.75M 22.57M 25.98M 25.32M 7.61M
Total Investments
81K 92K 80K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a